Ignite Creation Date:
2024-05-05 @ 11:26 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00046826
Status:
COMPLETED
Last Update Posted:
2013-04-04
First Post:
2002-10-03
Brief Title:
Docetaxel Estramustine and Thalidomide in Treating Patients With Prostate Cancer Previously Treated With Hormone Therapy
Sponsor:
Nuvance Health
Organization:
National Cancer Institute NCI
Organization Data
Organization:
National Cancer Institute NCI
Class:
NIH
Study ID:
CDR0000069081
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Nuvance Health
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None